Neonatal and Perinatal Infections

Pediatric Clinics of North America

Volumn 64, Issue 4, 2017, Pages 785-798

  Khan, Amira M ^a   Morris, Shaun K ^a   Bhutta, Zulfiqar A ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Antimicrobial resistance; Maternal health; Maternal infection; Neonatal morbidity; Neonatal mortality; Neonatal sepsis; Younger than 5 mortality

Indexed keywords

CHICKENPOX VACCINE; CHLORHEXIDINE; RUBELLA VACCINE; TETANUS TOXOID;

AMNIONITIS; ANTIBIOTIC RESISTANCE; CALORIC INTAKE; CHICKENPOX; COMMUNITY ACQUIRED INFECTION; CYTOMEGALOVIRUS INFECTION; DIET SUPPLEMENTATION; ENVIRONMENTAL FACTOR; EVIDENCE BASED MEDICINE; GROUP B STREPTOCOCCAL INFECTION; HAND WASHING; HEPATITIS B; HERPES SIMPLEX; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MATERNAL NUTRITION; MATERNAL WELFARE; NEWBORN INFECTION; NEWBORN PERIOD; NEWBORN SEPSIS; NEWBORN TETANUS; NONHUMAN; OMPHALITIS; PERINATAL INFECTION; PERINATAL PERIOD; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; RUBELLA; SYPHILIS; TOXOPLASMOSIS; ZIKA FEVER; COMMUNICABLE DISEASES; FEMALE; FETAL DISEASES; INFANT; INFANT MORTALITY; NEONATAL SEPSIS; NEWBORN; PREGNANCY;

COMMUNICABLE DISEASES; FEMALE; FETAL DISEASES; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; MATERNAL HEALTH; NEONATAL SEPSIS; PREGNANCY;

EID: 85025479018     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2017.03.008     Document Type: Review

References (44)

1. GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:10053 (2016), 1725–1774.
2. World Health Organization. Children: reducing mortality, 2016, World Health Organization Available at: http://www.who.int/mediacentre/factsheets/fs178/en/ Accessed October 20, 2016.
3. Khan, A.M., Bhutta, Z.A., Childhood infectious diseases: overview., 2nd edition Quah, S.R., Cockerham, W.C., (eds.) The international encyclopedia of public health, vol. 1, 2017, Academic Press, Oxford (United Kingdom), 517–538.
4. Lawn, J., Blencowe, H., Oza, S., et al. Every newborn: progress, priorities, and potential beyond survival. Lancet 384:9938 (2014), 189–205.
5. Velu, P.P., Gravett, C.A., Roberts, T.K., et al. Epidemiology and aetiology of maternal bacterial and viral infections in low- and middle-income countries. J Glob Health 1:2 (2011), 171–188.
6. Remington, J., Klein, J., Infectious diseases of the fetus and newborn infant. 1st edition, 2011, Saunders/Elsevier, Philadelphia.
7. Alam, M., Saleem, A., Shaikh, A., et al. Neonatal sepsis following prolonged rupture of membranes in a tertiary care hospital in Karachi, Pakistan. J Infect Dev Ctries 8:1 (2014), 67–73.
8. Hossain, M.M., Afroza, S., Shirin, M., et al. Bacterial aetiology of neonatal sepsis in a tertiary care hospital in Bangladesh. Bangladesh J Child Health 28 (2004), 81–85.
9. Global nutrition report: from promise to impact: ending malnutrition by 2030, 2016, International Food Policy Research Institute, Washington, DC Available at: http://globalnutritionreport.org/the-report/ Accessed October 29, 2016.
10. Schrag, S., Cutland, C., Zell, E., et al. Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa. Pediatr Infect Dis J 31:8 (2012), 821–826.
11. Iliodromiti, S., Mackay, D., Smith, G., et al. Apgar score and the risk of cause-specific infant mortality: a population-based cohort study. Lancet 384:9956 (2014), 1749–1755.
12. Society for Maternal-Fetal Medicine (SMFM), Hughes, B.L., Gyamfi-Bannerman, C., Diagnosis and antenatal management of congenital cytomegalovirus infection. Am J Obstet Gynecol 214:6 (2016), B5–B11.
13. Kimberlin, D., Jester, P., Sanchez, P., Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 372 (2015), 933–943.
14. World Health Organization. Zika causality statement, 2016, World Health Organization Available at: http://www.who.int/emergencies/zika-virus/causality/en/ Accessed November 02, 2016.
15. World Health Organization. The history of Zika, 2016, World Health Organization Available at: http://who.int/emergencies/zika-virus/history/en/ Accessed November 29, 2016.
16. França, G., Schuler-Faccini, L., Oliveira, W., et al. Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation. Lancet 388:10047 (2016), 891–897.
17. Pinninti, S., Kimberlin, D., Preventing herpes simplex virus in the newborn. Clin Perinatol 41:4 (2014), 945–955.
18. Kimberlin, D., Whitley, R., Wan, W., et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med 365:14 (2011), 1284–1292.
19. World Health Organization. Global health sector response to HIV, 2000-2015: focus on innovations in Africa: progress report, 2016, World Health Organization, Geneva (Switzerland) Available at: http://www.who.int/hiv/pub/progressreports/2015-progress-report/en/ Accessed November 11, 2016.
20. Galli, L., Martino, M., Tovo, P., et al. Onset of clinical signs in children with HIV-1 perinatal infection. Italian register for HIV infection in children. AIDS 9:5 (1995), 455–461.
21. Gentile, I., Borgia, G., Vertical transmission of hepatitis B virus: challenges and solutions. Int J Womens Health, 6, 2014, 605.
22. Nayagam, S., Thursz, M., Sicuri, E., et al. Requirements for global elimination of hepatitis B: a modelling study. Lancet Infect Dis 16:12 (2016), 1399–1408.
23. Nguyet-Cam, V.L., Gotsch, P.B., Langan, R.C., Caring for pregnant women and newborns with hepatitis B or C. Am Fam Physician 82:10 (2010), 1225–1229.
24. Laxminarayan, R., Bhutta, Z., Antimicrobial resistance—a threat to neonate survival. Lancet Glob Health 4:10 (2016), e676–e677.
25. Tshefu, A., Lokangaka, A., Ngaima, S., et al. Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial. Lancet 385:9979 (2015), 1767–1776.
26. Nair, H., Campbell, H., Community management of neonatal infections. Lancet 385:9979 (2015), 1706–1709.
27. World Health Organization. Pocket book of hospital care for children, 2nd edition, 2013, World Health Organization, Geneva (Switzerland).
28. Hibberd, P., Qazi, S., Population-based novel molecular diagnostics to move the neonatal sepsis agenda forward. Pediatr Infect Dis J 35 (2016), S1–S2.
29. World Health Organization, Guideline: managing possible serious bacterial infection in young infants when referral is not feasible. 2015, World Health Organization, Geneva (Switzerland) Available at: http://apps.who.int/iris/bitstream/10665/181426/1/9789241509268_eng.pdf Accessed November 15, 2016.
30. Edmond, K., Kortsalioudaki, C., Scott, S., et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 379:9815 (2012), 547–556.
31. Kobayashi, M., Vekemans, J., Baker, C., et al. Group B streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries. F1000Res, 5, 2016, 2355.
32. Saha, S., Arifeen, S., Schrag, S., Aetiology of neonatal infection in South Asia (ANISA): An initiative to identify appropriate program priorities to save newborns. Pediatr Infect Dis J 35 (2016), S6–S8.
33. Bhutta, Z., Das, J., Bahl, R., et al. Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?. Lancet 384:9940 (2014), 347–370.
34. Blencowe, H., Lawn, J., Vandelaer, J., et al. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol 39:Suppl 1 (2010), i102–i109.
35. Turab, A., Pell, L., Bassani, D., et al. The community-based delivery of an innovative neonatal kit to save newborn lives in rural Pakistan: design of a cluster randomized trial. BMC Pregnancy Childbirth, 14(1), 2014, 315.
36. Cousens, S., Blencowe, H., Gravett, M., et al. Antibiotics for pre-term pre-labour rupture of membranes: prevention of neonatal deaths due to complications of pre-term birth and infection. Int J Epidemiol 39:Suppl 1 (2010), i134–i143.
37. Mullany, L., Darmstadt, G., Khatry, S., et al. Topical applications of chlorhexidine to the umbilical cord for prevention of omphalitis and neonatal mortality in southern Nepal: a community-based, cluster-randomised trial. Lancet 367:9514 (2006), 910–918.
38. Soofi, S., Cousens, S., Imdad, A., et al. Topical application of chlorhexidine to neonatal umbilical cords for prevention of omphalitis and neonatal mortality in a rural district of Pakistan: a community-based, cluster-randomised trial. Lancet 379:9820 (2012), 1029–1036.
39. Sazawal, S., Dhingra, U., Ali, S., et al. Efficacy of chlorhexidine application to umbilical cord on neonatal mortality in Pemba, Tanzania: a community-based randomised controlled trial. Lancet Glob Health 4:11 (2016), e837–e844.
40. Semrau, K., Herlihy, J., Grogan, C., et al. Effectiveness of 4% chlorhexidine umbilical cord care on neonatal mortality in Southern Province, Zambia (ZamCAT): a cluster-randomised controlled trial. Lancet Glob Health 4:11 (2016), e827–e836.
41. Salam, R., Das, J., Darmstadt, G., et al. Emollient therapy for preterm newborn infants – evidence from the developing world. BMC Public Health, 13(Suppl 3), 2013, S31.
42. Victora, C., Bahl, R., Barros, A., et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 387:10017 (2016), 475–490.
43. Laxminarayan, R., Matsoso, P., Pant, S., et al. Access to effective antimicrobials: a worldwide challenge. Lancet 387:10014 (2016), 168–175.
44. Investigators of the Delhi Neonatal Infection Study (DeNIS) Collaboration. Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study. Lancet Glob Health 4:10 (2016), e752–e760.